Overview
Sophie Lotersztajn practices practicing medicine in Paris, France.
Ms. Lotersztajn is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Cirrhosis, Non-Alcoholic Fatty Liver Disease, Alcoholic Cirrhosis, and Obesity.
She is actively involved in clinical research, co-authoring 64 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sophie Lotersztajn
Is Sophie Lotersztajn a top-rated expert for Cirrhosis?
MediFind is an objective health platform that identifies experts based on real-world data. Sophie Lotersztajn is classified as an Distinguished expert for Cirrhosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sophie Lotersztajn participate in research or clinical trials?
Yes. Sophie Lotersztajn has published 64 articles and abstracts on conditions like Cirrhosis. You can view a list of Sophie Lotersztajn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CirrhosisMs. Lotersztajn isDistinguished. Learn about Cirrhosis.
- Advanced
- Alcoholic CirrhosisMs. Lotersztajn isAdvanced. Learn about Alcoholic Cirrhosis.
- Non-Alcoholic Fatty Liver DiseaseMs. Lotersztajn isAdvanced. Learn about Non-Alcoholic Fatty Liver Disease.
- Experienced
- Alpha-1 Antitrypsin Deficiency (AATD)Ms. Lotersztajn isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- CholangitisMs. Lotersztajn isExperienced. Learn about Cholangitis.
- HepatitisMs. Lotersztajn isExperienced. Learn about Hepatitis.
- Liver CancerMs. Lotersztajn isExperienced. Learn about Liver Cancer.
- Liver FailureMs. Lotersztajn isExperienced. Learn about Liver Failure.
- Nonalcoholic Steatohepatitis (NASH)Ms. Lotersztajn isExperienced. Learn about Nonalcoholic Steatohepatitis (NASH).
- ObesityMs. Lotersztajn isExperienced. Learn about Obesity.
- Sclerosing CholangitisMs. Lotersztajn isExperienced. Learn about Sclerosing Cholangitis.
- Subcutaneous EmphysemaMs. Lotersztajn isExperienced. Learn about Subcutaneous Emphysema.